Linking the population epidemiology of acute renal failure, chronic kidney disease and end-stage renal disease

Current Opinion in Nephrology and Hypertension

Volumn 16, Issue 3, 2007, Pages 221-226

  Hsu, Chi Yuan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT;

ACUTE KIDNEY FAILURE; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIALYSIS; GLOMERULOPATHY; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; MORTALITY; NEPHROTOXICITY; PREVALENCE; PRIORITY JOURNAL; REVIEW;

CHRONIC DISEASE; EPIDEMIOLOGY; HUMANS; INCIDENCE; KIDNEY DISEASES; KIDNEY FAILURE, ACUTE; KIDNEY FAILURE, CHRONIC; PREVALENCE;

EID: 34247243123     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e3280895ad9     Document Type: Review

References (20)

1. Gilbertson DT, Liu J, Xue JL, et al. Projecting the number of patients with endstage renal disease in the United States to the year 2015. J Am Soc Nephrol 2005; 16:3736-3741.
2. Port FK. The end-stage renal disease program: trends over the past 18 years. Am J Kidney Dis 1992; 20:3-7.
3. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266.
4. Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41:1-12.
5. Hsu CY, Vittinghoff E, Lin F, Shlipak MG. The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med 2004; 141:95-101.
6. Coresh J, Byrd-Holt D, Astor BC, et al. Chronic kidney disease awareness, prevalence, and trends among US adults, 1999 to 2000. J Am Soc Nephrol 2005; 16:180-188.
7. Hsu CY, Go AS, McCulloch CE, et al. Exploring secular trends in the likelihood of receiving treatment for end-stage renal disease. Clin J Am Soc Nephrol 2007; 2:81-88.
8. Muntner P, Coresh J, Powe NR, Klag MJ. The contribution of increased diabetes prevalence and improved myocardial infarction and stroke survival to the increase in treated end-stage renal disease. J Am Soc Nephrol 2003; 14:1568-1577.
9. US Renal Data System. Patient Characteristics. 2006 Annual Data Report. http://www.usrds.org/2006/ref/C_pt_char_06.pdf (accessed 26 December 2006).
10. Stewart JH, McCredie MR, Williams SM, McDonald SP. Interpreting incidence trends for treated end-stage renal disease: Implications for evaluating disease control in Australia. Nephrology (Carlton) 2004; 9:238-246.
11. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-1305.
12. Waikar SS, Wald R, Chertow GM, et al. Validity of international classification of diseases, ninth revision: clinical modification codes for acute renal failure. J Am Soc Nephrol 2006; 17:1688-1694.
13. Liangos O, Wald R, O'Bell JW, et al. Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol 2006; 1:43-51.
14. Waikar SS, Curhan GC, Wald R, et al. Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol 2006; 17:1143-1150.
15. Bhandari S, Turney JH. Survivors of acute renal failure who do not recover renal function. QJM 1996; 89:415-421.
16. US Renal Data System. Incidence of reported ESRD. 2006 Annual Data Report. http://www.usrds.org/2006/ref/A_incidence_06.pdf (accessed 26 December 2006).
17. Basile DP, Fredrich K, Alausa M, et al. Identification of persistently altered gene expression in the kidney after functional recovery from ischemic acute renal failure. Am J Physiol Renal Physiol 2005; 288:F953-F963.
18. Burne-Taney MJ, Liu M, Ascon D, et al. Transfer of lymphocytes from mice with renal ischemia can induce albuminuria in naive mice: a possible mechanism linking early injury and progressive renal disease? Am J Physiol Renal Physiol 2006; 291:F981-F986.
19. Stengel B, Couchoud C. Chronic kidney disease prevalence and treated endstage renal disease incidence: a complex relationship. J Am Soc Nephrol 2006; 17:2094-2096.
20. Hallan SI, Coresh J, Astor BC, et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006; 17:2275-2284.